Downregulation of uPAR inhibits migration, invasion, proliferation, FAK/PI3K/Akt signaling and induces senescence in papillary thyroid carcinoma cells

References

• Wartofsky L. Increasing world incidence of thyroid cancer: increased detection or higher radiation exposure?. Hormones (Athens) 2010; 9:103 - 108; PMID: 20687393
   PubMedGoogle Scholar
• Roh JL, Park JY, Park CI. Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients. Ann Surg 2007; 245:604 - 610; PMID: 17414610; http://dx.doi.org/10.1097/01.sla.0000250451.59685.67
   PubMed Web of Science ®Google Scholar
• Lee YS, Lim YS, Lee JC, Wang SG, Kim IJ, Lee BJ. Clinical implication of the number of central lymph node metastasis in papillary thyroid carcinoma: preliminary report. World J Surg 2010; 34:2558 - 2563; PMID: 20703463; http://dx.doi.org/10.1007/s00268-010-0749-0
   PubMed Web of Science ®Google Scholar
• Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Engl J Med 1998; 338:297 - 306; PMID: 9445411
   PubMed Web of Science ®Google Scholar
• Fagin JA, Tuttle RM, Pfister DG. Harvesting the low-hanging fruit: kinase inhibitors for therapy of advanced medullary and nonmedullary thyroid cancer. J Clin Endocrinol Metab 2010; 95:2621 - 2624; DOI: 20525911 PMID: 20525911
   PubMed Web of Science ®Google Scholar
• Rubino C, de Vathaire F, Dottorini ME, Hall P, Schvartz C, Couette JE, et al. Secondary primary malignancies in thyroid cancer patients. Br J Cancer 2003; 89:1638 - 1644; PMID: 12973856; http://dx.doi.org/10.1038/sj.bjc.6601319
   PubMed Web of Science ®Google Scholar
• Smith HW, Marshall CJ. Regulation of cell signaling by uPAR. Nat Rev Mol Cell Bio 2010; 11:23 - 36; PMID: 20027185; http://dx.doi.org/10.1038/nrm2821
   PubMed Web of Science ®Google Scholar
• Gondi CS, Rao JS. Therapeutic potential of siRNA-mediated targeting of urokinase plasminogen activator, its receptor and matrix metalloproteinases. Methods Mol Biol 2009; 487:267 - 281; PMID: 19301652
   PubMedGoogle Scholar
• Soares P, Trovisco V, Rocha AS, Lima J, Castro P, Preto A, et al. BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene 2003; 22:4578 - 4580; PMID: 12881714; http://dx.doi.org/10.1038/sj.onc.1206706
   PubMed Web of Science ®Google Scholar
• Lengyel E, Wang H, Stepp E, Juarez J, Wang Y, Doe W, et al. Requirement of an upstream AP-1 motif for the constitutive and phorbol ester-inducible expression of the urokinase-type plasminogen activator receptor gene. J Biol Chem 1996; 271:23176 - 23184; PMID: 8798512; http://dx.doi.org/10.1074/jbc.271.38.23176
   PubMed Web of Science ®Google Scholar
• Bessard A, Frémin C, Ezan F, Coutant A, Baffet G. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells. J Cell Physiol 2007; 212:526 - 536; PMID: 17427199; http://dx.doi.org/10.1002/jcp.21049
   PubMed Web of Science ®Google Scholar
• Ulisse S, Baldini E, Toller M, Marchioni E, Giacomelli L, De Antoni E, et al. Differential expression of the components of the plasminogen activating system in human thyroid tumour derived cell lines and papillary carcinomas. Eur J Cancer 2006; 42:2631 - 2638; PMID: 16928445; http://dx.doi.org/10.1016/j.ejca.2006.04.017
   PubMed Web of Science ®Google Scholar
• Nowicki TS, Kummer NT, Iacob C, Suslina N, Schaefer S, Schantz S, et al. Inhibition of uPAR and uPA reduces invasion in papillary thyroid carcinoma cells. Laryngoscope 2010; 120:1383 - 1390; PMID: 20578104; http://dx.doi.org/10.1002/lary.20915
   PubMed Web of Science ®Google Scholar
• Schaller MD, Hildebrand JD, Shannon JD, Fox JW, Vines RR, Parsons JT. Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol Cell Biol 1994; 14:1680 - 1688; PMID: 7509446
   PubMed Web of Science ®Google Scholar
• Chen HC, Appeddu PA, Isoda H, Guan JL. Phosphorylation of tyrosine 397 in focal adhesion kinase is required for binding phosphatidylinositol-3-kinase. J Biol Chem 1996; 271:26329 - 26334; PMID: 8824286; http://dx.doi.org/10.1074/jbc.271.42.26329
   PubMed Web of Science ®Google Scholar
• Zhao H, Halicka HD, Traganos F, Jorgensen E, Darzynkiewicz Z. New biomarkers probing the depth of cell senescence assessed by laser scanning cytometry. Cytometry Part A 2010; 77:999 - 1007; PMID: 20939035; http://dx.doi.org/10.1002/cyto.a.20983
   PubMed Web of Science ®Google Scholar
• Itahana K, Campisi J, Dimri GP. Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay. Methods Mol Biol 2007; 371:21 - 31; PMID: 17634571
   PubMedGoogle Scholar
• Basolo F, Torregrossa L, Giannini R, Miccoli M, Lupi C, Sensi E, et al. Correlation between the BRAFV600E mutation and tumor invasiveness in papillary thyroid carcinomas smaller than 20 millimeters: Analysis of 1,060 Cases. J Clin Endocrinol Metab 2010; 95:4197 - 4205; PMID: 20631031; http://dx.doi.org/10.1210/jc.2010-0337
   PubMed Web of Science ®Google Scholar
• Mesa C Jr, Mirza M, Mitsutake N, Sartor M, Medvedovic M, Tomlinson C, et al. Conditional activation of RET/PTC3 and BRAFV600E in thyroid cells is associated with gene expression profiles that predict a preferential role of BRAF in extracellular matrix remodeling. Cancer Res 2006; 66:6521 - 6529; PMID: 16818623; http://dx.doi.org/10.1158/0008-5472.can-06-0739
   PubMed Web of Science ®Google Scholar
• Nguyen T, Menocal EM, Harborth J, Fruehauf JH. RNAi therapeutics: An update on delivery. Curr Opin Mol Ther 2008; 10:158 - 167; PMID: 18386228
   PubMed Web of Science ®Google Scholar
• Rye PD, Stigbrand T. Interfering with cancer: a brief outline of advances in RNA interference in oncology. Tumor Biol 2004; 25:329 - 336; PMID: 15627900
   PubMed Web of Science ®Google Scholar
• Wilda M, Fuchs U, Wössmann W, Borkhardt A. Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi). Oncogene 2002; 21:5716 - 5724; PMID: 12173041; http://dx.doi.org/10.1038/sj.onc.1205653
   PubMed Web of Science ®Google Scholar
• Gondi CS, Kandhukuri N, Dinh DH, Gujrati M, Rao JS. Downregulation of uPAR and uPA activates caspase-mediated apoptosis and inhibits the PI3K/AKT pathway. Int J Oncol 2007; 31:19 - 27; PMID: 17549401
   PubMed Web of Science ®Google Scholar
• Falasca M. PI3K/Akt signalling pathway specific inhibitors: A novel strategy to sensitize cancer cells to anti-cancer drugs. Curr Pharm Des 2010; 16:1410 - 1416; PMID: 20166984
   PubMed Web of Science ®Google Scholar
• Liang X, Yang X, Tang Y, Zhou H, Liu X, Xiao L, et al. RNAi-mediated downregulation of urokinase plasminogen activator receptor inhibits proliferation, adhesion, migration and invasion in oral cancer cells. Oral Oncol 2008; 44:1172 - 1180; PMID: 18486529; http://dx.doi.org/10.1016/j.oraloncology.2008.03.004
   PubMed Web of Science ®Google Scholar
• Cristofali VJ, Pignolo RJ. Replicative senescence of human fibroblast-like cells in culture. Physiol Rev 1993; 78:617 - 625; PMID: 8332640
   PubMed Web of Science ®Google Scholar
• Hwang ES, Yoon G, Kang HT. A comparative analysis of the cell biology of senescence and aging. Cell Mol Life Sci 2009; 66:2503 - 2524; PMID: 19421842; http://dx.doi.org/10.1007/s00018-009-0034-2
   PubMed Web of Science ®Google Scholar
• Darzynkiewicz Z, Traganos F, Melamed MR. New cell cycle compartments identified by multiparameter flow cytometry. Cytometry 1980; 1:98 - 108; PMID: 6170495
   PubMedGoogle Scholar
• Traganos F, Darzynkiewicz Z, Sharpless T, Melamed MR. Erythroid differentiation of Friend leukemia cells as studies by acridine orange staining and flow cytometry. J Histochem Cytochem 1979; 27:382 - 389; PMID: 86567
   PubMed Web of Science ®Google Scholar
• Pospelova TV, Demidenko ZN, Bukreeva EI, Pospelov VA, Gudkov AV, Blagosklonny MV. Pseudo-DNA damage response in senescent cells. Cell Cycle 2009; 8:4112 - 4118; PMID: 19946210
   PubMed Web of Science ®Google Scholar
• Darzynkiewicz Z. When senescence masquerades as DNA damage: is DNA replication stress the culprit?. Cell Cycle 2009; 8:3810 - 3811; PMID: 19887905
   PubMed Web of Science ®Google Scholar
• Collado M, Medema RH, Garcia-Cao I, Dubuisson ML, Barradas M, Glassford J, et al. Inhibition of the phosphoinositide 3-kinase pathway induces a senescence-like arrest mediated by p27Kip1. J Biol Chem 2000; 275:21960 - 21968; PMID: 10791951; http://dx.doi.org/10.1074/jbc.M000759200
   PubMed Web of Science ®Google Scholar
• Axanova LS, Chen YQ, McCoy T, Sui G, Cramer SD. 1,25-dihydroxyvitamin D(3) and PI3K/AKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cells. Prostate 2010; 70:1658 - 1671; PMID: 20583132; http://dx.doi.org/10.1002/pros.21201
   PubMed Web of Science ®Google Scholar
• Sumikawa E, Matsumoto Y, Sakemura R, Fujii M, Ayusawa D. Prolonged unbalanced growth induces cellular senescence markers linked with mechano transduction in normal and tumor cells. Biochem Biophys Res Commun 2005; 335:558 - 565; PMID: 16083852; http://dx.doi.org/10.1016/j.bbrc.2005.07.106
   PubMed Web of Science ®Google Scholar
• Korotchkina LG, Leontieva OV, Bukreeva EI, Demidenko ZN, Gudkov AV, Blagosklonny MV. The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway. Aging 2010; 2:344 - 352; PMID: 20606252
   PubMedGoogle Scholar
• Demidenko ZN, Shtutman M, Blagosklonny MV. Pharmacologic inhibition of MEK and PI-3K converges on the mTOR/S6 pathway to decelerate cellular senescence. Cell Cycle 2009; 8:1896 - 1900; PMID: 19478560
   PubMed Web of Science ®Google Scholar
• Demidenko ZN, Zubova SG, Bukreeva EI, Pospelov VA, Pospelova TV, Blagosklonny MV. Rapamycin decelerates cellular senescence. Cell Cycle 2009; 8:1888 - 1895; PMID: 19471117
   PubMed Web of Science ®Google Scholar
• Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM, et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 2005; 436:720 - 724; PMID: 16079850; http://dx.doi.org/10.1038/nature03890
   PubMed Web of Science ®Google Scholar
• Courtois-Cox S, Genther William SM, Reczek EE, Johnson BW, McGillicuddy LT, Johannessen CM, et al. A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell 2006; 10:459 - 472; PMID: 17157787; http://dx.doi.org/10.1016/j.ccr.2006.10.003
   PubMed Web of Science ®Google Scholar